This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit December 10, 2014    SLAS2015    Moving? New job? Let SLAS know.    









Drive to DC Program for Students and Early Career Professionals
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Would you like SLAS to pay for your gas to SLAS2105?

Participate in the SLAS2015 Drive to DC program. The first 30 teams of Students and Early Career Pros to sign up for this new program will have their gas expenses (up to $150) reimbursed. Take and tweet pictures of your SLAS2015 Drive to DC car magnet along the way to #SLAS2015 and #DrivetoDC for a chance to win the Kerouac Prize of $100 cash.

Sign up for Drive to DC program is required by Jan. 23, 2015 — contact Mary Geismann to register for this program and for more details. The Drive to DC program is just one of many perks for young scientists attending SLAS2015. Check the website for registration discounts, career workshops, counseling sessions and networking events with food and drink.


SLAS ELN Reports: Marc Bickle — A Quest for Cell Culture Relevance
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS member Marc Bickle, Ph.D., is fascinated with cell culture and its link to life sciences. He is also obsessed with data quantification. His interests led him from researching worms to yeast to high-content screening and beyond, now as head of the Technology Development Studio of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany.

Read more about this SLAS2015 Short Course instructor, JBS Editorial Board member and guest editor of the upcoming JBS special issue, Screening by RNAi and Precise Genome Editing Technologies, in the SLAS Electronic Laboratory Neighborhood e-zine.


JALA Special Issue Call for Manuscript Proposals: High-Throughput Imaging Technologies
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Guest Editor Michael Kuo, M.D., invites manuscript proposals by April 1.

"Rapid improvements in imaging capabilities, including advances in molecular imaging and radiogenomics, are enabling the non-invasive capture of macroscopic and subcellular features," Kuo states.

"Thus, imaging is no longer a tool of simple detection but is now being used to characterize and quantify disease, predict treatment response and guide and select therapy, provide insights into fundamental biology and identify and localize molecular targets. In this issue, we will highlight and explore diverse imaging approaches and their applications."

Introducing BAMS: Bead-Assisted Mass Spectrometry
BAMS brings a new paradigm to mass spectrometry by combining bead-based multiplexing and plate-based self-assembly. Available Now by Early Access!

SLAS Online Learning — Growing to Meet Education Needs
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
The SLAS Online Learning Center allows SLAS members to experience conference quality professional education from the comfort of home or office. In 2014, the SLAS eLearning Advisory Committee re-engineered its approach to SLAS Webinars, shifting from a series model of three related presentations to individual, single topic-focused presentations. The change was well received and live audience levels increased while the catalog of SLAS Webinars On-Demand grew to nearly 40. Recently added to the recordings list are: March and April 2015 SLAS Webinar topics and speakers also are on the website. More


Attention JALA & JBS Authors & Reviewers: Update Your Info & Opt-in Today
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Be sure you receive important e-mail announcements by updating your personal profile information in the JALA and JBS SAGEtrack systems. Pay special attention to your "attributes" (areas of expertise) selections and be sure to "OPT-IN," so SLAS can keep you informed of special issues and other publication opportunities.
  • JALA SAGEtrack Users: Login, click on your name (top/right of homepage), select User ID & Password from the dropdown menu.
  • JBS SAGEtrack Users: Login, click on your name (top/right of homepage), select User ID & Password from the dropdown menu.

Welcome Genedata — New SLAS Corporate Member
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Headquartered in Switzerland, Genedata transforms data into intelligence with a portfolio of advanced software solutions to make research data accessible and understandable and research processes more efficient. The Genedata Screener captures, visualizes and manages data from high, medium and low-throughput screens performed with a range of technologies on a wide array of instruments, including high-content screening, ion channel screening and label-free screening. The software's screening-oriented business logic enables rapid processing and comprehensive analysis of complete campaigns, regardless of the number of plates or read-outs. More

iCell Cardiomyocytes: True Human Biology
• Functional, mixed population of atrial, ventricular, nodal cells
• Confirmed utility in identifying therapeutic approaches
• Demonstrated value in targeted and phenotypic screening

Learn More
Cloud Solutions Designed with Scientists in Mind
  • Save time and money with
       Acquire™ lab supplies
       management software.
  • Streamline compound
       management with Store™
  • Make internal and external
       compounds and assays
       accessible to all project
       teams with Request™
  • Visualize™ enables
       securely sharing compound
       and biological assay results.
  • Advertisement
    Cytation 3 Cell Imaging Multi-Mode Reader
    Cytation™ 3 is a cell imaging multi-mode microplate reader that combines automated digital microscopy and conventional microplate detection. This unique patent pending design provides rich phenotypic cellular information with well-based quantitative data.

    Click here to learn more.


    Drug Development in a Time of Ebola
    Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Forbes kicked off the 2014 Healthcare Summit with this session titled, "Drug Development in A Time of Ebola." Forbes senior editor Matthew Herper interviewed Edward Cox and Lucianna Borio, two high-ranking officials at the U.S. Food and Drug Administration. Cox leads the Office of Antimicrobial Products along with the Center for Drug Evaluation and Research, while Borio serves as the Assistant Commissioner for Counterterrorism Policy. More

    Nanoparticle Cluster Manufacturing Technique Using DNA Binding Protein Developed
    Science Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Scientists in South Korea used the Zinc Finger protein to develop a new manufacturing technique for size-controllable magnetic Nanoparticle Clusters. Professor Hak-Sung Kim of the Department of Biological Sciences at Korea Advanced Institute of Science and Technology and Yiseul Ryu, a doctoral candidate, used the Zinc Finger protein that specifically binds to target DNA sequence to develop a new manufacturing technique for size-controllable magnetic Nanoparticle Clusters. More


    Single-Cell Analysis Hints at Stem Cell Code Linking Transcription and Development
    Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Exercising unprecedented delicacy, researchers probed the regulatory circuits that govern the transitions between stem cells' pluripotent states. The researchers uncovered far more variation in pluripotent stem cells than was previously appreciated. In addition, they learned that there are many small fluctuations in the state of a stem cell's pluripotency that can influence which developmental path it will follow. More

    Chemists Create 'Artificial Chemical Evolution' for First Time    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Scientists have taken an important step towards the possibility of creating synthetic life with the development of a form of artificial evolution in a simple chemistry set without DNA. A team from the University of Glasgow's School of Chemistry report in the journal Nature Communications how they have managed to create an evolving chemical system for the first time. The process uses a robotic "aid" and could be used in the future to "evolve" new chemicals capable of performing specific tasks. More

    It's All About Your Data
    During SLAS, visit CDD (Booth 1155) to see how you can effortlessly store, analyze, & mine your biological study data & chemical structures with CDD Vault®. Finally, a modern approach to drug research informatics. Click here!
    Cloud, Consulting, and Custom Services, All In One.
    Scigilian is a software company specializing in offering solutions to the problems encountered in pharmaceutical research, biotechnology, and contract research. Trusted, from large pharma to small CRO.

    Making Chemistry Green
    The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    For nearly 40 years, the Food and Drug Administration has wrestled with regulating the chemicals triclosan and triclocarban as they have become among the world's most ubiquitous environmental contaminants. Designed to kill bacteria, they have been added to antibacterial soaps, cosmetics and other consumer products despite longstanding concerns about their impacts on humans and the environment. More

    Unusual Electronic State Found in New Class of Unconventional Superconductors
    Lab Manager    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    A team of scientists from the U.S. Department of Energy's Brookhaven National Laboratory, Columbia Engineering, Columbia Physics and Kyoto University has discovered an unusual form of electronic order in a new family of unconventional superconductors. The finding, described in the journal Nature Communications, establishes an unexpected connection between this new group of titanium-oxypnictide superconductors and the more familiar cuprates and iron-pnictides. More

    Mixed Signals
    Chemical & Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Within a week of publication of C&EN's 2013 Pharmaceutical Year in Review, a new drug called Sovaldi was introduced. Like others before, it came with a backstory and kicked off a new adventure for the firm that developed it and the patients, physicians and payers that populate the market. In the case of Sovaldi, a highly effective treatment for hepatitis C, the narrative illuminates the key issues and dilemmas characterizing the drug industry in 2014. More

    Expanding the Analytical Toolbox: Pharmaceutical Application of Quantitative NMR
    Analytical Chemistry    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    In response to the changing market pressures being applied to the pharmaceutical industry, a greater emphasis is being made to advance new drugs to market with minimal investment in early development stages. The use of quantitative NMR (q-NMR) has been shown to be a single point replacement for routine early development testing which previously combined elements of identity testing, chromatographic assay, moisture analysis, residual solvent analysis, and elemental analysis. More

    New! CellTiter-Glo® 2.0 Assay
    Same high performance as the original assay, now provided as a single reagent— ready-to-use with storage stability at 4°C or room temperature.

    No mixing. No thawing. No waste.

    Request a FREE sample today in your lab.
    Saf-T-Pak 6.2 Compliance Training, Now Offering CEUs
    6.2 Shipping Training is required biennially – when was the last time you trained? All training is conducted in accordance with the regulations published by IATA, ICAO, US DOT, Transport Canada, RID/ADR and the Universal Postal Union
    Real-Time Monitoring Cardiomyocyte Beating
    The xCELLigence RTCA Cardio System monitors cardiomyocyte beating functions in a 96-well format under physiological conditions, using a noninvasive label-free impedance-based technology. Rule out both acute and long-term cardiotoxicity in a single experiment. For more information, please visit


    Manager/Senior Manager, R&D – Lab Automation
    US – MD – Gaithersburg

    Clinical Project Manager
    Translational Drug Development
    US – AZ – Scottsdale

    Analytical Scientist
    Nal Pharma
    US – NJ – Monmouth Junction

    More jobs at SLAS Career Connections


    SLAS Point-to-Point
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Dennis Hall, Executive Editor, 469.420.2656   
    Contribute news

    This edition of SLAS Point-to-Point was sent to ##Email##. To unsubscribe from receiving SLAS Point-to-Point, click here. To unsubscribe from all SLAS e-mail communications, please click here. Did someone forward this edition to you? Subscribe here — it's free!

    SLAS Terms of Use Policy
    Recent issues

    Dec. 3, 2014
    Nov. 26, 2014
    Nov. 19, 2014

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063